Krystal Biotech Inc (KRYS)
182.47
+4.37
(+2.45%)
USD |
NASDAQ |
Nov 21, 16:00
182.47
0.00 (0.00%)
After-Hours: 19:58
Krystal Biotech Price to Book Value: 5.924 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.782 |
| November 19, 2024 | 5.774 |
| November 18, 2024 | 5.702 |
| November 15, 2024 | 5.543 |
| November 14, 2024 | 5.759 |
| November 13, 2024 | 5.981 |
| November 12, 2024 | 6.078 |
| November 11, 2024 | 6.359 |
| November 08, 2024 | 6.481 |
| November 07, 2024 | 6.021 |
| November 06, 2024 | 5.944 |
| November 05, 2024 | 5.662 |
| November 04, 2024 | 5.547 |
| November 01, 2024 | 5.727 |
| October 31, 2024 | 5.602 |
| October 30, 2024 | 5.699 |
| October 29, 2024 | 5.721 |
| October 28, 2024 | 5.743 |
| October 25, 2024 | 5.698 |
| October 24, 2024 | 5.680 |
| October 23, 2024 | 5.608 |
| October 22, 2024 | 5.688 |
| October 21, 2024 | 5.810 |
| October 18, 2024 | 5.817 |
| October 17, 2024 | 5.740 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.771 |
| October 15, 2024 | 5.793 |
| October 14, 2024 | 5.830 |
| October 11, 2024 | 5.801 |
| October 10, 2024 | 5.621 |
| October 09, 2024 | 5.583 |
| October 08, 2024 | 5.676 |
| October 07, 2024 | 5.681 |
| October 04, 2024 | 5.750 |
| October 03, 2024 | 5.711 |
| October 02, 2024 | 5.758 |
| October 01, 2024 | 5.891 |
| September 30, 2024 | 5.909 |
| September 27, 2024 | 6.067 |
| September 26, 2024 | 6.110 |
| September 25, 2024 | 6.148 |
| September 24, 2024 | 6.146 |
| September 23, 2024 | 6.171 |
| September 20, 2024 | 6.307 |
| September 19, 2024 | 6.318 |
| September 18, 2024 | 6.258 |
| September 17, 2024 | 6.482 |
| September 16, 2024 | 6.653 |
| September 13, 2024 | 6.904 |
| September 12, 2024 | 6.700 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.169
Minimum
Nov 26 2021
7.328
Maximum
Jun 13 2023
4.225
Average
3.966
Median
Price to Book Value Benchmarks
| Bioventus Inc | 5.063 |
| ADMA Biologics Inc | 21.71 |
| Alnylam Pharmaceuticals Inc | 984.20 |
| Amicus Therapeutics Inc | 15.85 |
| Rhythm Pharmaceuticals Inc | 323.20 |
Price to Book Value Related Metrics
| PE Ratio | 102.51 |
| PS Ratio | 22.23 |
| Price to Free Cash Flow | 92.46 |
| Price | 182.47 |
| Earnings Yield | 0.98% |
| Market Cap | 5.248B |
| Operating PE Ratio | 82.65 |
| Normalized PE Ratio | 62.75 |